Clinical Trial Update: SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated switching HIV-1 infection patients to a once-daily Truvada regimen; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 4 | Status: COMPLETED